Maria Khan Junaidi: How Age Influences Intracerebral Hemorrhage Outcomes
Maria Khan Junaidi, Deputy Program Director Vascular Neurology at Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in European Stroke Journal, adding:
“Pleased to share our latest publication in the European Stroke Journal.
Clinical characteristics and outcomes of intracerebral haemorrhage in young vs. older adults: Insights from the INTERACT3 trial.
In this secondary analysis of 7,031 patients across 10 countries, we found that although younger adults (լess than or equal to 50 years) with ICH often had larger haematomas and a distinct vascular risk profile, they experienced significantly better 6-month outcomes and appeared to derive greater benefit from bundled acute ICH care.
These findings reinforce the importance of early, protocol-driven management while highlighting the need for targeted prevention strategies in younger patients with ICH.
Grateful to all collaborators and the INTERACT3 investigators for making this work possible.”
Title: Clinical characteristics and outcomes of intracerebral haemorrhage in young vs older adults: insights from the INTERACT3 trial
Authors: Maria Khan, Menglu Ouyang, Mohammad Wasay, Lu Ma, Xin Hu, Xiaoying Chen, Laurent Billot, Qiang Li, Paula Muñoz Venturelli, Asita de Silva, Nguyen Huy Thang, Kolawole W Wahab, Jeyaraj D Pandian, Octavio M Pontes-Neto, Carlos Abanto, Antonio Arauz, Chao You, Lili Song, Craig S Anderson

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series